BlackRock’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $97.9M | Sell |
|
|||||
|
2025
Q1 | $88.1M | Buy |
|
|||||
|
2024
Q4 | $101M | Buy |
|
|||||
|
2024
Q3 | $98.8M | Sell |
|
|||||
|
2024
Q2 | $78.8M | Buy |
|
|||||
|
2024
Q1 | $73.4M | Buy |
|
|||||
|
2023
Q4 | $25.7M | Buy |
|
|||||
|
2023
Q3 | $16.8M | Buy |
|
|||||
|
2023
Q2 | $27.2M | Buy |
|
|||||
|
2023
Q1 | $25.9M | Sell |
|
|||||
|
2022
Q4 | $13.9M | Buy |
|
|||||
|
2022
Q3 | $19.9M | Buy |
|
|||||
|
2022
Q2 | $19.3M | Sell |
|
|||||
|
2022
Q1 | $25.1M | Sell |
|
|||||
|
2021
Q4 | $35.7M | Buy |
|
|||||
|
2021
Q3 | $49.7M | Sell |
|
|||||
|
2021
Q2 | $70.6M | Sell |
|
|||||
|
2021
Q1 | $96.3M | Buy |
|
|||||
|
2020
Q4 | $114M | Buy |
|
|||||
|
2020
Q3 | $31.1M | Buy |
|
|||||
|
2020
Q2 | $30.1M | Buy |
|
|||||
|
2020
Q1 | $14.2M | Buy |
|
|||||
|
2019
Q4 | $11.2M | Sell |
|
|||||
|
2019
Q3 | $9.34M | Buy |
|
|||||
|
2019
Q2 | $12.9M | Buy |
|
|||||
|
2019
Q1 | $11.3M | Buy |
|
|||||
|
2018
Q4 | $11.1M | Buy |
|
|||||
|
2018
Q3 | $15.8M | Buy |
|
|||||
|
2018
Q2 | $13.3M | Buy |
|
|||||
|
2018
Q1 | $11M | Buy |
|
|||||
|
2017
Q4 | $6.31M | Buy |
|
|||||
|
2017
Q3 | $8.7M | Buy |
|
|||||
|
2017
Q2 | $12.8M | Buy |
|
|||||
|
2017
Q1 | $12M | Buy |
|
|||||
|
2016
Q4 | $22K | Buy |
|
|||||
|
2016
Q3 | $8K | Hold |
|
|||||
|
2016
Q2 | $6K | Buy |
|
|||||
|
2016
Q1 | $9K | Buy |
|
|||||
|
2015
Q4 | $3K | Hold |
|
|||||
|
2015
Q3 | $5K | Hold |
|
|||||
|
2015
Q2 | $7K | Buy |
|